Skip to main content
logo
Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0250
-0.0196 (-43.95%)
Inactive · Last trade price on Apr 13, 2026

Novakand Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-29.59-29.59-46.16-66.08-52.69-46.96
Net Income
-47.23-47.23-44.57-64.89-52.48-45.69
Earnings Per Share
-0.39-0.39-0.39-0.81-0.90-0.82
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16.0716.0746.3645.6995.15106.52
Total Debt
-----0.57
Net Cash (Debt)
16.0716.0746.3645.6995.15105.95
Net Cash Growth
-65.33%-65.33%1.47%-51.98%-10.20%97.36%
Net Cash Per Share
0.130.130.400.571.641.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-30.29-30.29-58.53-55.67-47.56-44.13
Capital Expenditures
------
Free Cash Flow
-30.29-30.29-58.53-55.67-47.56-44.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------